Jaguar Health (JAGX) Prepaid Assets (2014 - 2026)
Jaguar Health's (JAGX) quarterly Prepaid Assets came in at $2.0 million in Q1 2026, down 84.01% year-on-year from $12.8 million in Q1 2025, and down 7.63% on a QoQ basis from $2.2 million in Q4 2025.
Jaguar Health (JAGX) Prepaid Assets (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Prepaid Assets data on file, last reported at $2.0 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 84.01% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 84.01% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 81.84% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.0 million, down from $2.2 million in the prior quarter.
- Over the last five years, Prepaid Assets for JAGX reached as high as $13.7 million in Q3 2025 and fell as low as $2.0 million in Q1 2026.
- Historically, Prepaid Assets has averaged $9.0 million across 5 years, with a median of $9.8 million in 2023.
- Across the five-year window, Prepaid Assets surged 102.52% in 2023 and sank 84.01% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $7.4 million in 2022, then surged by 37.49% to $10.1 million in 2023, then climbed by 20.58% to $12.2 million in 2024, then sank by 81.84% to $2.2 million in 2025, then fell by 7.63% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $2.0 million in Q1 2026, $2.2 million in Q4 2025, and $13.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | 13.74 Mn |
| Jun 30, 2025 | 13.66 Mn |
| Mar 31, 2025 | 12.81 Mn |
| Dec 31, 2024 | 12.20 Mn |
| Sep 30, 2024 | 12.39 Mn |
| Jun 30, 2024 | 13.14 Mn |
| Mar 31, 2024 | 11.31 Mn |
| Dec 31, 2023 | 10.12 Mn |
| Sep 30, 2023 | 8.61 Mn |
| Jun 30, 2023 | 9.78 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 7.36 Mn |
| Sep 30, 2022 | 5.59 Mn |
| Jun 30, 2022 | 5.53 Mn |
| Mar 31, 2022 | 3.88 Mn |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 4.91 Mn |
| Jun 30, 2021 | 4.81 Mn |